Lv51
910 积分 2024-09-29 加入
Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2022 and 2023
6小时前
已完结
hERG toxicity assessment: Useful guidelines for drug design
6小时前
已完结
Summary of major conclusions from the 7th International Workshop on Genotoxicity Testing (IWGT), Tokyo, Japan
6小时前
求助中
In vivo genotoxicity testing strategies: Report from the 8th International Workshop on Genotoxicity Testing ( IWGT )
6小时前
已完结
New Modalities and Carcinogenicity Assessment
16天前
已完结
Carcinogenicity Risk Assessment of Targeted Protein Degraders
16天前
已完结
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider
16天前
已完结
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs
22天前
已完结
Discovery of 6-Fluoro-5-{4-[(5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD9574): A CNS-Penetrant, PARP1-Selective Inhibitor
22天前
已完结
Preclinical Characterization of AZD9574, a Blood–Brain Barrier Penetrant Inhibitor of PARP1
22天前
已完结